(2E)-1-(3-bromophenyl)-3-(2,5-dimethoxyphenyl)prop-2-en-1-one, 95.0%, 10g

2-Aminopropanamide, 95.0%, 25g

6-Cyanobenzothiazole, 95.0%, 2.5g

2-Methylpiperidine, 98.0%, 25g

N-[(11bR)-2,6-Bis([1,1'-biphenyl]-4-yl)-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl]-1,1,1-trifluoromethanesulfonamide, 98%, 250mg

(R)-7-Hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, 95.0%, 1g

3-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoic acid, 95.0%, 100mg

Ethyl 5-Bromo-1,3,4-oxadiazole-2-carboxylate, 97.0%, 1g

N-[4-[5-(1,3-Benzodioxol-5-yl)-3-methoxy-1H-1,2,4-triazol-1-yl]phenyl]-2-(phenylthio)acetamide, 98%, 25mg

Bomba de vacío de membrana LABOPORT® con control de velocidad serie N 800 G, N 840 G, 34 l/min, 1 pieza

Accesorios para reactores agitadores GL 80 Agitador de anclaje de repuesto, 1 pieza

N-(Pyridin-4-ylmethyl)ethanamine, 97.0%, 1g

(R)-METHYL 2-(PYRROLIDIN-1-YL)PROPANOATE, 95.0%, 5g